BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

MedImmune

MedImmune Incorporated is a biotechnology company headquartered in Gaithersburg, Maryland with three products on themarket and a diverse product development portfolio. MedImmune is focused on using advances in immunology and other biological sciences to develop important new products that address significant medical needs in areas such as infectious diseases, transplantation medicine, autoimmune diseases and cancer. In 1998, the Company launched Synagis (palivizumab) in the United States for preventing respiratory syncytial virus (RSV) in high-risk pediatric patients. Synagis is the first monoclonal antibody approved for an infectious disease and has become an important new pediatric product for the prevention of RSV, the leading cause of pneumonia and bronchiolitis in infants and children. The Company also markets CytoGam (Cytomegalovirus Immune Globulin Intravenous (Human), CMV-IGIV) and RespiGam (Respiratory Syncytial Virus

Immune Globulin Intravenous (Human), RSV-IGIV) and has five new product candidates undergoing clinical trials.


Contact Details:
One MedImmune Way
Gaithersburg
MD
20878
United States of America
Tel:(301) 398-0000
Fax:301 527 4200
Email:infobusdev@medimmune.com
WWW:

www.MedImmune.com/




Loading...

Recent Publications by MedImmune:

Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
FluMist is an intranasal influenza live vaccine containing two Influenza A...
18th July, 2008
MedImmune Vaccines Inc., 297 N. Bernardo Avenue, Mountain View, J Virol Methods. 2008 Jun;150(1-2):63-9.
DOI Direct Link
The role of IL-21 in regulating B-cell function in health and disease.
SUMMARY: Interleukin-21 (IL-21) belongs to a family of cytokines that...
11th July, 2008
Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal Immunol Rev. 2008 Jun;223:60-86.
DOI Direct Link
Duration of Protection Provided by Live Attenuated Influenza Vaccine in Children.
BACKGROUND:: Reliable availability of influenza vaccine before October...
5th July, 2008
From MedImmune, Gaithersburg, MD. Pediatr Infect Dis J. 2008 Jul 2;.
DOI Direct Link
Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters.
BACKGROUND: Human metapneumovirus (hMPV) infection can cause acute lower...
4th July, 2008
Research Dept, MedImmune, Mountain View, CA 94043, USA. Virol J. 2008 Jun 3;5:69.
DOI Direct Link
A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
The appearance of human infections caused by avian influenza A H7 subtype...
1st July, 2008
Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA; Virology. 2008 Jun 26;.
DOI Direct Link

View more MedImmune research publications.

BioNews Results for MedImmune:

::: MedImmune in exclusive agreement with Virosome
Biotech Intelligence:  Jul 18 2008 8:32PM Matching: medimmune
Norwood Abbey: Virosome, MedImmune collaborate
Business Spectator:  Jul 17 2008 6:14AM Matching: medimmune
Norwood Immunology Signs Evaluation Agreement With MedImmune
Morningstar.com:  Jul 16 2008 10:08AM Matching: medimmune
UK smallcap opening - Norwood Immunology up on MedImmune deal
CNBC:  Jul 16 2008 8:40AM Matching: medimmune
Norwood Immunology signs exclusive vaccine evaluation agreement with MedImmune
CNBC:  Jul 16 2008 8:40AM Matching: medimmune
Promote your company here: BioNewsCast - Press Release Distribution

View more MedImmune news.

MedImmune Patents:

US Patent No.Title
6692749 Non-splicing variants of gp350/220
6887480 Streptococcus pneumoniae proteins and vaccines
6887699 Recombinant negative strand RNA virus expression systems and vaccines
6908613 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
6913750 Therapeutic compounds structurally-linked to bacterial polypeptides

View more MedImmune patents.

MedImmune (MEDI) Financial information Links from Barchart

MEDI Quote from from Barchart.com
MEDI Chart from from Barchart.com
MEDI Profile from from Barchart.com
MEDI Opinion from from Barchart.com

View more MedImmune finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 39 individuals from MedImmune using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 463 times since April 2007, the link to the organisation's website has been followed 78 times

Recent Search Terms used to find this page: medimmune proteins department | medimmune | medimmune and human papillomavirus | medimmune publications | Contact details of Medimmune | recent publications from medimmune | animal model and drug testing and company | medimmune.com | synagis | Brian Rosen Medimmune Inc. contact info | .

Search for more companies in Gaithersburg

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MedImmune
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.